SOX2 and breast cancer: ALDH activity and other commonly used stem cell markers including CD24, CD44, SOX2 expression, mammosphere-forming ability, and the SP phenotype were variably present in populations from human breast cancer tissue and breast cancer cell lines and identified cancer cell subpopulations with no reliable therapeutic implications [73].